{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:28:11Z","timestamp":1792106891413,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00520-024-08998-y","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T12:08:18Z","timestamp":1732018098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic trajectories of patients with rare cancer in the Netherlands: results from a nationwide cross-sectional survey"],"prefix":"10.1007","volume":"32","author":[{"given":"Catarina S.","family":"Padilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"de Heus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milou J. P.","family":"Reuvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Schrieks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Grunhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot E. T.","family":"Tesselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winette T. A.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia F. A.","family":"Duijts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"issue":"17","key":"8998_CR1","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","volume":"47","author":"G Gatta","year":"2011","unstructured":"Gatta G et al (2011) Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer 47(17):2493\u2013511","journal-title":"Eur J Cancer"},{"key":"8998_CR2","unstructured":"Research NCIEG. Synergizing epidemiologic research on rare cancers. 2017; Available from: https:\/\/epi.grants.cancer.gov\/events\/rare-cancer\/"},{"issue":"6","key":"8998_CR3","doi-asserted-by":"publisher","first-page":"e13461","DOI":"10.1111\/ecc.13461","volume":"30","author":"O Husson","year":"2021","unstructured":"Husson O et al (2021) Supportive care needs of patients living with an extremely rare and unpredictable cancer: the Epithelioid Haemangioendothelioma patient experience. Eur J Cancer Care (Engl) 30(6):e13461","journal-title":"Eur J Cancer Care (Engl)"},{"key":"8998_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejca.2017.02.006","volume":"77","author":"I Ray-Coquard","year":"2017","unstructured":"Ray-Coquard I et al (2017) Improving treatment results with reference centres for rare cancers: where do we stand? Eur J Cancer 77:90\u201398","journal-title":"Eur J Cancer"},{"issue":"8","key":"8998_CR5","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/S1470-2045(17)30445-X","volume":"18","author":"G Gatta","year":"2017","unstructured":"Gatta G et al (2017) Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol 18(8):1022\u20131039","journal-title":"Lancet Oncol"},{"issue":"2","key":"8998_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1470-2045(15)00485-4","volume":"17","author":"KM Komatsubara","year":"2016","unstructured":"Komatsubara KM, Carvajal RD (2016) The promise and challenges of rare cancer research. Lancet Oncol 17(2):136\u2013138","journal-title":"Lancet Oncol"},{"key":"8998_CR7","doi-asserted-by":"publisher","first-page":"100861","DOI":"10.1016\/j.lanepe.2024.100861","volume":"39","author":"JY Blay","year":"2024","unstructured":"Blay JY et al (2024) Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN. Lancet Reg Health Eur 39:100861","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"8998_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13023-021-01886-2","volume":"16","author":"E de Heus","year":"2021","unstructured":"de Heus E et al (2021) Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey. Orphanet J Rare Dis 16(1):249","journal-title":"Orphanet J Rare Dis"},{"key":"8998_CR9","unstructured":"EURACAN. 2021; Available from: https:\/\/euracan.eu\/who-we-are\/about-euracan\/"},{"key":"8998_CR10","unstructured":"Organization, W.H. (2013) International classification of diseases for oncology (ICD-O) \u2013 3rd edition, 1st revision. 3 ed. WHO Press. Available from: https:\/\/www.who.int\/standards\/classifications\/other-classifications\/international-classification-of-diseases-for-oncology"},{"key":"8998_CR11","unstructured":"EuroBloodNet (2024) Clinical practice guidelines and other clinical decision making tools; Available from: https:\/\/eurobloodnet.eu\/best-practices\/guidelines-and-recommendations\/"},{"key":"8998_CR12","unstructured":"RARECARENet. RARECARENet cancer list 2015 [cited 2023 21\/07\/2023]."},{"key":"8998_CR13","unstructured":"EuroBloodNet. 2021; Available from: https:\/\/eurobloodnet.eu\/eurobloodnet\/who-we-are\/"},{"key":"8998_CR14","unstructured":"Surveymonkey. 2021; Available from: https:\/\/nl.surveymonkey.com\/"},{"key":"8998_CR15","unstructured":"Nederland HSHOV. Ziektebeelden. 2024; Available from: https:\/\/www.hematon.nl\/ziektebeelden"},{"key":"8998_CR16","unstructured":"Hematon HEMATON 2024; Available from: https:\/\/www.hematon.nl\/"},{"issue":"644","key":"8998_CR17","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.3399\/bjgp16X683977","volume":"66","author":"SC Mendonca","year":"2016","unstructured":"Mendonca SC, Abel GA, Lyratzopoulos G (2016) Pre-referral GP consultations in patients subsequently diagnosed with rarer cancers: a study of patient-reported data. Br J Gen Pract 66(644):e171-81","journal-title":"Br J Gen Pract"},{"issue":"8","key":"8998_CR18","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.ejso.2017.02.017","volume":"43","author":"M de Ridder","year":"2017","unstructured":"de Ridder M et al (2017) Variation in head and neck cancer care in the Netherlands: a retrospective cohort evaluation of incidence, treatment and outcome. Eur J Surg Oncol 43(8):1494\u20131502","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"8998_CR19","doi-asserted-by":"publisher","first-page":"e0243439","DOI":"10.1371\/journal.pone.0243439","volume":"15","author":"V Soomers","year":"2020","unstructured":"Soomers V et al (2020) The route to diagnosis of sarcoma patients: results from an interview study in the Netherlands and the United Kingdom. PLoS One 15(12):e0243439","journal-title":"PLoS One"},{"key":"8998_CR20","unstructured":"Institute TNC. Skin cancer and melanoma center. 2023 [cited 2023 09\/11]; Available from: https:\/\/www.avl.nl\/en\/preparing-for-your-appointment\/departments-and-centers\/nki-skin-cancer-and-melanoma-center\/#expertise"},{"issue":"3","key":"8998_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18(3):170\u2013186","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"8998_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","volume":"33","author":"S Popat","year":"2022","unstructured":"Popat S et al (2022) Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2606). Ann Oncol 33(2):129\u2013142","journal-title":"Ann Oncol"},{"key":"8998_CR23","unstructured":"van der Zwan JM (2016) Surveillance of rare cancers. https:\/\/research.utwente.nl\/en\/publications\/surveillance-of-rare-cancers"},{"key":"8998_CR24","unstructured":"Engelen V, Schrieks M (2019) Choosing a hospital for cancer: what do you think is important?(Dutch: Een ziekenhuis kiezen bij kanker: wat vind jij belangrijk?) Utrecht: Dutch Federation of Cancer Patient Organisations (Nederlandse Federatie van Kankerpatientenorganisaties, NFK). Available from: https:\/\/doneerjeervaring.nl\/peilingen\/een-ziekenhuis-kiezen-bij-kanker-wat-vind-jij-belangrijk"},{"key":"8998_CR25","unstructured":"IKNL (2023) Cijfers rapport 'Zeldzame kanker: Organisatie van expertise\u2019. Available from: https:\/\/iknl.nl\/kankersoorten\/zeldzame-kanker\/registratie\/cijfers-rapport-organisatie-van-expertise"},{"issue":"6","key":"8998_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","volume":"83","author":"OR Brouwer","year":"2023","unstructured":"Brouwer OR et al (2023) European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update. Eur Urol 83(6):548\u2013560","journal-title":"Eur Urol"},{"key":"8998_CR27","doi-asserted-by":"publisher","unstructured":"Rushbrook SM, Kendall TJ, Zen Y, Albazaz R, Manoharan P, Pereira SP, Sturgess R, Davidson BR, Malik HZ, Manas D, Heaton N, Prasad KR, Bridgewater J, Valle JW, Goody R, Hawkins M, Prentice W, Morement H, Walmsley M, Khan, SA (2023) British society of gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut 73(1):16\u201346. Available from: https:\/\/doi.org\/10.1136\/gutjnl-2023-330029","DOI":"10.1136\/gutjnl-2023-330029"},{"issue":"1","key":"8998_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13643-019-1017-5","volume":"8","author":"C Bell","year":"2019","unstructured":"Bell C et al (2019) Communication strategies for rare cancers: a systematic review protocol. Syst Rev 8(1):102","journal-title":"Syst Rev"},{"issue":"4","key":"8998_CR29","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s11764-022-01324-7","volume":"17","author":"E Driehuis","year":"2023","unstructured":"Driehuis E et al (2023) Quality of life of patients with rare cancer: a comparison with patients with colorectal cancer and the association with disease trajectory-related factors. J Cancer Surviv 17(4):986\u2013996","journal-title":"J Cancer Surviv"},{"issue":"6","key":"8998_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/oxfordjournals.aje.a009487","volume":"147","author":"MM Bergmann","year":"1998","unstructured":"Bergmann MM et al (1998) Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 147(6):556\u201362","journal-title":"Am J Epidemiol"},{"issue":"2","key":"8998_CR31","doi-asserted-by":"publisher","first-page":"100012","DOI":"10.1016\/j.rare.2023.100012","volume":"2024","author":"CS Padilla","year":"2024","unstructured":"Padilla CS et al (2024) Measuring health-related quality of life in solid rare cancer patients: a study protocol. Rare 2024(2):100012","journal-title":"Rare"},{"issue":"6","key":"8998_CR32","doi-asserted-by":"publisher","first-page":"e13502","DOI":"10.1111\/ecc.13502","volume":"30","author":"E de Heus","year":"2021","unstructured":"de Heus E et al (2021) Unmet supportive care needs of patients with rare cancer: a systematic review. Eur J Cancer Care (Engl) 30(6):e13502","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"1","key":"8998_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12955-024-02244-z","volume":"22","author":"L Rojas-Concha","year":"2024","unstructured":"Rojas-Concha L et al (2024) Acceptability and usefulness of the EORTC \u2018Write In three Symptoms\/Problems\u2019 (WISP): a brief open-ended instrument for symptom assessment in cancer patients. Health Qual Life Outcomes 22(1):28","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"8998_CR34","doi-asserted-by":"publisher","first-page":"e13509","DOI":"10.1111\/ecc.13509","volume":"30","author":"AR Frissen","year":"2021","unstructured":"Frissen AR et al (2021) Experiences of healthcare professionals with support for mesothelioma patients and their relatives: identified gaps and improvements for care. Eur J Cancer Care (Engl) 30(6):e13509","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"Suppl 2","key":"8998_CR35","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1038\/sj.bjc.6605383","volume":"101 Supple 2","author":"F Olesen","year":"2009","unstructured":"Olesen F, Hansen RP, Vedsted P (2009) Delay in diagnosis: the experience in Denmark. Br J Cancer 101 Supple 2(Suppl 2):S5-8","journal-title":"Br J Cancer"},{"key":"8998_CR36","doi-asserted-by":"crossref","unstructured":"de Heus E et al (2023) The solitary versus supported experience: care inequality between rare and common cancer patients. Psychooncology","DOI":"10.1002\/pon.6216"},{"key":"8998_CR37","unstructured":"IDEA4RC. IDEAR4C - an intelligent data ecosystem for rare cancers. 2024; Available from: https:\/\/www.idea4rc.eu\/"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08998-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08998-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08998-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T15:06:20Z","timestamp":1733756780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08998-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8998"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08998-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As participants were not involved in an intervention, the Medical Research Involving Human Subjects Act (WMO) does not apply, and according to WMO, ethical approval is not required (2020.257).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"807"}}